Immix Biopharma Sets June 20th Annual Meeting
Ticker: IMMX · Form: DEFA14A · Filed: May 5, 2025 · CIK: 1873835
Sentiment: neutral
Topics: proxy-statement, annual-meeting
TL;DR
Immix Biopharma's annual meeting is June 20th, 2025. Get ready to vote.
AI Summary
Immix Biopharma, Inc. has filed a Definitive Additional Materials proxy statement (DEFA14A) on May 5, 2025, related to its Annual Meeting of Stockholders scheduled for June 20, 2025. The meeting will take place at 12:00 p.m. EDT. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing informs shareholders about the upcoming annual meeting where key corporate decisions are made and directors are elected, impacting the company's future direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating immediate financial distress or significant corporate events.
Key Players & Entities
- Immix Biopharma, Inc. (company) — Registrant
- June 20, 2025 (date) — Annual Meeting Date
- 12:00 p.m. EDT (time) — Annual Meeting Time
- DEFA14A (document) — Filing Type
- May 5, 2025 (date) — Filing Date
FAQ
When is the Immix Biopharma, Inc. Annual Meeting of Stockholders?
The Annual Meeting of Stockholders of Immix Biopharma, Inc. will be held on June 20, 2025.
What time is the Annual Meeting scheduled for?
The meeting is scheduled for 12:00 p.m. EDT.
What type of SEC filing is this?
This is a Definitive Additional Materials proxy statement (DEFA14A).
Who is the filer of this proxy statement?
The registrant, Immix Biopharma, Inc., is the filer.
What is the fiscal year end for Immix Biopharma, Inc.?
The fiscal year end for Immix Biopharma, Inc. is December 31.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 5, 2025 regarding Immix Biopharma, Inc. (IMMX).